Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease

Brain Research

Volumn 1095, Issue 1, 2006, Pages 207-210

  Zhang, Xiaoqun ^a   Andren, Per E ^b   Svenningsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Basal ganglia; BDNF; Immediate early gene; Movement disorder

Indexed keywords

BENSERAZIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; LEVODOPA; MESSENGER RNA; OXIDOPAMINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN NUCLEUS; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBTHALAMIC NUCLEUS;

ADRENERGIC AGENTS; ANIMALS; ANTIPARKINSON AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COCAINE; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; LEVODOPA; MALE; OXIDOPAMINE; PARKINSON DISEASE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBTHALAMIC NUCLEUS; TRITIUM;

EID: 33745000075     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.019     Document Type: Article

References (24)

1. Baufreton J., Garret M., Rivera A., de la Calle A., Gonon F., Dufy B., Bioulac B., and Taupignon A. D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J. Neurosci. 23 (2003) 816-825
2. Benabid A.L. Deep brain stimulation for Parkinson's disease. Curr. Opin. Neurobiol. 13 (2003) 696-706
3. Brown L.L., Markman M.H., Wolfson L.I., Dvorkin B., Warner C., and Katzman R. A direct role of dopamine in the rat subthalamic nucleus and an adjacent intrapeduncular area. Science 206 (1979) 1416-1418
4. Engber T.M., Susel Z., Kuo S., Gerfen C.R., and Chase T.N. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Brain Res. 552 (1991) 113-118
5. Francois C., Savy C., Jan C., Tande D., Hirsch E.C., and Yelnik J. Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients. J. Comp. Neurol. 425 (2000) 121-129
6. Fumagalli F., Racagni G., and Riva M.A. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. Pharmacogenomics J. 6 (2006) 95-104
7. Garcia L., D'Alessandro G., Bioulac B., and Hammond C. High-frequency stimulation in Parkinson's disease: more or less?. Trends Neurosci. 28 (2005) 209-216
8. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.-C., and Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411 (2001) 86-89
9. Guridi J., and Obeso J.A. The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. Brain 124 (2001) 5-19
10. Hornykiewicz O. Chemical neuroanatomy of the basal ganglia-normal and in Parkinson's disease. J. Chem. Neuroanat. 22 (2001) 3-12
11. Mehta A., Thermos K., and Chesselet M.F. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions. Synapse 37 (2000) 298-307
12. Murer M.G., Yan Q., and Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog. Neurobiol. 63 (2001) 71-124
13. Ni Z., Gao D., Bouali-Benazzouz R., Benabid A.L., and Benazzouz A. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway. Eur. J. Neurosci. 14 (2001) 373-381
14. Nielsen K.M., and Soghomonian J.J. Dual effects of intermittent or continuous l-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion. Synapse 49 (2003) 246-260
15. Olds M.E., Jacques D.B., and Kopyov O. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra. Synapse 34 (1999) 228-240
16. Paul M.L., Graybiel A.M., David J.C., and Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12 (1992) 3729-3742
17. Rite I., Machado A., Cano J., and Venero J.L. Divergent regulatory mechanisms governing BDNF mRNA expression in cerebral cortex and substantia nigra in response to striatal target ablation. Exp. Neurol. 192 (2005) 142-155
18. Ruskin D.N., and Marshall J.F. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Brain Res. 703 (1995) 156-164
19. Seroogy K.B., and Numan S. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J. Comp. Neurol. 403 (1999) 295-308
20. Shen K.Z., Zhu Z.T., Munhall A., and Johnson S.W. Dopamine receptor supersensitivity in rat subthalamus after 6-hydroxydopamine lesions. Eur. J. Neurosci. 18 (2003) 2967-2974
21. Svenningsson P., and Le Moine C. Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptors. Eur. J. Neurosci. 15 (2002) 133-142
22. Svenningsson P., Le Moine C., Kull B., Sunahara R., Bloch B., and Fredholm B.B. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80 (1997) 1171-1185
23. Svenningsson P., Gunne L., and Andren P.E. l-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset. Neuroscience 99 (2000) 457-468
24. Zhang J., Zhang D., McQuade J.S., Behbehani M., Tsien J.Z., and Xu M. c-fos regulates neuronal excitability and survival. Nat. Genet. 30 (2002) 416-420